About FDA
Number of pre-Animal Generic Drug User Fee Act (AGDUFA) generic new animal drug submissions reviewed and completed during the month
Dictionary: A generic new animal drug is a copy of an approved new animal drug for which patents or other periods of exclusivity are near expiration. In order for a generic animal drug to be marketed in the United States, it must be the subject of an approved ANADA. Prompt evaluation of applications for generic new animal drugs enhances the cost-effectiveness and predictability of new animal drug development. The effect of reducing the backlog of generic new animal drug submissions is anticipated to increase the number of generic new animal drug applications submitted.
Fiscal Year - 2010
| Time | Target | Number |
|---|---|---|
| Oct 2009 | N/A | 39 |
| Nov 2009 | N/A | 24 |
| Dec 2009 | N/A | 15 |
| Jan 2010 | N/A | 24 |
| Feb 2010 | N/A | 6 |
| Mar 2010 | N/A | 13 |
| Apr 2010 | N/A | 8 |
| May 2010 | N/A | 0 |
| Jun 2010 | N/A | 0 |
| Jul 2010 | N/A | 0 |
| Aug 2010 | N/A | 3 |
| Sep 2010 | N/A | 0 |
FY 2010 Overall: 132
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
